5 Matching Annotations
  1. Jan 2026
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12809113/
  3. Jul 2025
  4. aacrjournals.org aacrjournals.org
    PF-08046032: A Novel, Investigational CD25-Directed Antibody–Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/mct/article/24/7/963/763162/PF-08046032-A-Novel-Investigational-CD25-Directed
  5. May 2025
  6. 52.53.155.43 52.53.155.43
    PDF-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/8722bce88cb39afedfdfb86cbdceb511fd6e5381/PDF-html.html
  7. Mar 2025
  8. www.sciencedirect.com www.sciencedirect.com
    A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379125001028
  9. Apr 2023
  10. aacrjournals.org aacrjournals.org
    IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/3/4/576/725855/IOA-244-is-a-Non-ATP-competitive-Highly-Selective